Back to top
more

HCA Healthcare (HCA)

(Delayed Data from NYSE)

$404.66 USD

404.66
3,447,724

+1.14 (0.28%)

Updated Sep 20, 2024 04:00 PM ET

After-Market: $404.42 -0.24 (-0.06%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

2-Buy of 5   2      

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

B Value B Growth F Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 1% (3 out of 251)

Industry: Medical - Hospital

Better trading starts here.

Zacks News

Sheraz Mian headshot

Q2 Earnings Season Scorecard and Analyst Reports for Netflix, Wells Fargo & Comcast

Today's Research Daily features a real-time update on the Q2 earnings season and new research reports on Netflix (NFLX), Wells Fargo (WFC) and Comcast (CMCSA) and others.

Community Health (CYH) Q2 Earnings Miss on Lower Patient Days

Community Health's (CYH) second-quarter earnings suffer a setback from lower admissions and patient days. Improved occupancy levels partially offset the negatives.

Universal Health (UHS) Q2 Earnings Beat on Acute Care Strength

Universal Health's (UHS) second-quarter results benefit from the rising number of patients in the Acute Care Unit. Declining admissions in the Behavioral Health segment partially offset the positives.

Here's Why HCA Healthcare (HCA) is a Strong Momentum Stock

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Why HCA Healthcare (HCA) is a Top Stock for the Long-Term

The Zacks Focus List offers investors a way to easily find top-rated stocks and build a winning investment portfolio. Here's why you should take advantage.

Tenet Healthcare Corporation (THC) Hit a 52 Week High, Can the Run Continue?

Tenet (THC) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Nilanjan Choudhury headshot

Bet on These 5 Attractive Relative Price Strength Plays

STX, RGA, HCA, IP and OSW are five stocks with explosive relative price strength.

Tenet (THC) Q2 Earnings Beat on Patient Volumes, '24 EPS View Up

Tenet Healthcare's (THC) Q2 results reflect net revenue per case growth, higher pricing yield and a decline in overall expenses. It expects 2024 adjusted EPS within $10.41-$11.12, up from the previous guidance of $8.37-$9.41.

Shaun Pruitt headshot

2 Standout Stocks to Buy After Beating Earnings Expectations

Now looks like a promising time to invest in the increased profitability of HCA Healthcare (HCA) and Spotify Technology (SPOT) after beating Q2 earnings expectations on Tuesday.

HCA Healthcare (HCA) Beats on Q2 Earnings, Ups 2024 EPS View

HCA Healthcare (HCA) increases its 2024 EPS in the range of $21.60-$22.8, the midpoint implying growth of 17% from the 2023 figure.

Compared to Estimates, HCA (HCA) Q2 Earnings: A Look at Key Metrics

Although the revenue and EPS for HCA (HCA) give a sense of how its business performed in the quarter ended June 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

HCA Healthcare (HCA) Surpasses Q2 Earnings and Revenue Estimates

HCA (HCA) delivered earnings and revenue surprises of 10.66% and 2.22%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?

Bio-Rad (BIO) to Report Q2 Earnings: What's in the Cards?

Within Bio-Rad's (BIO) Life Science business, the ongoing weakness in the biotech and biopharma end markets might have severely impacted sales.

Strong CAG Sales to Aid IDEXX Laboratories' (IDXX) Q2 Earnings

IDEXX Laboratories' (IDXX) second-quarter 2024 results are likely to reflect the benefits of strong execution against the growth strategy.

Is HCA Healthcare (HCA) Stock Outpacing Its Medical Peers This Year?

Here is how HCA Healthcare (HCA) and AnaptysBio, Inc. (ANAB) have performed compared to their sector so far this year.

Here's How Labcorp (LH) is Placed Ahead of Q2 Earnings Release

Labcorp's (LH) second-quarter 2024 performance is expected to reflect the robust execution of strategic priorities and solid business performances.

Kaibalya Pravo Dey headshot

Buying Tenet (THC) Pre-Q2 Earnings: A Prescription for Profits?

Tenet Healthcare's (THC) second-quarter earnings are likely to have benefited from higher admissions, average length of stay and patient days.

Backlog Conversion Likely to Aid Medpace's (MEDP) Q2 Earnings

Continued strength in backlog conversion rate is likely to have boosted Medpace's (MEDP) top line in the second quarter.

What's in Store for Texas Instruments (TXN) in Q2 Earnings?

Texas Instruments' (TXN) second-quarter 2024 results are likely to reflect the adverse impacts of a weak demand environment and increasing manufacturing costs.

4 Healthcare Stocks Poised to Beat Q2 Earnings Estimates

Expanding aging population and the increasing demand for affordable health products are likely to have boosted the performance of healthcare stocks in Q2. CI, UHS, HCA & THC are potential outperformers.

Will Clear Aligner Sales Drive Align Technology's (ALGN) Q2 Earnings?

Align Technology's (ALGN) second-quarter results are likely to reflect the strength in its Clear Aligner and Systems & Services businesses.

Hologic's (HOLX) Surgical Business Set to Propel Q3 Earnings

Hologic (HOLX) is likely to have delivered impressive performances across the GYN Surgical and Breast Health businesses in the third quarter of fiscal 2024.

Can HCA Healthcare (HCA) Beat Q2 Earnings on Growing Admissions?

HCA Healthcare's (HCA) second-quarter earnings are likely to benefit from improved admissions and payer mix, partially offset by rising operating expenses.

Will Patient Volumes Drive Universal Health's (UHS) Q2 Earnings?

Universal Health's (UHS) Q2 performance is likely to gain from strong performances in its Acute Care Hospital Services and Behavioral Health Care Services segments.

Tenet Healthcare (THC) Reports Next Week: Wall Street Expects Earnings Growth

Tenet (THC) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.